This adjustment accompanies the firm's reiteration of a Buy rating for the stock. The coverage transition from the Precision Team to the Healthcare Team at Jefferies is reflective of Olympus ...
(NASDAQ: ACLX) shares, raising it to $122 from the previous $83 while maintaining a "Buy" rating on the stock. The revision comes amid discussions on the safety of BCMA-CAR-T therapies ...
Roper Technologies raised its full-year profit and revenue forecasts above Wall Street estimates on Wednesday on improved demand for its enterprise software services that cater to industries including ...
On Monday, Jefferies upgraded shares of AptarGroup (NYSE:ATR), a company listed on the New York Stock Exchange under the ticker NYSE:ATR, from Hold to Buy and significantly increased the price target ...